Clinical, trichoscopic, and folliscopic identification of the impact of metabolic syndrome on the response to intradermal dutasteride 0.02% injection in patients with female pattern hair loss: a prospective cohort study

References

• Olsen EA. Female pattern hair loss. J Am Acad Dermatol. 2001;45(3):S70–S80.
   PubMed Web of Science ®Google Scholar
• Blume-Peytavi U, Blumeyer A, Tosti A, the European Consensus Group, et al. S1 guideline for diagnostic evaluation in androgenetic alopecia in men, women and adolescents. Br J Dermatol. 2011;164(1):5–15.
   PubMed Web of Science ®Google Scholar
• Trüeb RM. Molecular mechanisms of androgenetic alopecia. Exp Gerontol. 2002;37(8-9):981–990.
   PubMed Web of Science ®Google Scholar
• Gan DC, Sinclair RD. Prevalence of male and female pattern hair loss in Maryborough. J Invest Dermatol Symp Proc. 2005;10(3):184–189.
   PubMedGoogle Scholar
• Cash TF. The psychology of hair loss and its implications for patient care. Clin Dermatol. 2001;19(2):161–166.
   PubMed Web of Science ®Google Scholar
• Reid EE, Haley AC, Borovicka JH, et al. Clinical severity does not reliably predict quality of life in women with alopecia areata, telogen effluvium, or androgenic alopecia. J Am Acad Dermatol. 2012;66(3):e97–e102.
   PubMed Web of Science ®Google Scholar
• Donk J, Passchier J, Knegt-Junk C, et al. Psychological characteristics of women with androgenetic alopecia: a controlled study. Br J Dermatol. 1991;125(3):248–252.
   PubMed Web of Science ®Google Scholar
• Clark RV, Hermann DJ, Cunningham GR, et al. Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5-alpha reductase inhibitor. J Clin Endocrinol Metab. 2004;89(5):2179–2184.
   PubMed Web of Science ®Google Scholar
• Moftah N, Moftah N, Abd-Elaziz G, et al. Mesotherapy using dutasteride containing preparation in treatment of female pattern hair loss: photographic, morphometric and ultrustructural evaluation. J Eur Acad Dermatol Venereol. 2013;27(6):686–693.
   PubMed Web of Science ®Google Scholar
• Hawk E, Breslow RA, Graubard BI. Male pattern baldness and clinical prostate cancer in the epidemiologic follow-up of the first National Health and Nutrition Examination Survey. Cancer Epidemiol Biomark Prev. 2000;9:523–527.
   PubMed Web of Science ®Google Scholar
• Yassa M, Saliou M, De Rycke Y, et al. Male pattern baldness and the risk of prostate cancer. Ann Oncol. 2011;22(8):1824–1827.
   PubMed Web of Science ®Google Scholar
• Giles GG, Severi G, Sinclair R, et al. Androgenetic alopecia and prostate cancer: findings from an Australian case-control study. Cancer Epidemiol Biomark Prev. 2002;11:549–553.
   PubMed Web of Science ®Google Scholar
• Lie C, Liew CF, Oon HH. Alopecia and the metabolic syndrome. Clin Dermatol. 2018;36(1):54–61.
   PubMed Web of Science ®Google Scholar
• Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37(12):1595–1607.
   PubMed Web of Science ®Google Scholar
• Defronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diab Care. 1991;14(3):173–194.
   PubMed Web of Science ®Google Scholar
• Lindsay RS, Howard BV. Cardiovascular risk associated with the metabolic syndrome. Curr Diab Rep. 2004;4(1):63–68.
   PubMedGoogle Scholar
• Su LH, Chen TH. Association of androgenetic alopecia with metabolic syndrome in men: a community-based survey. Br J Dermatol. 2010;163(2):371–377.
   PubMed Web of Science ®Google Scholar
• Bakry OA, Shoeib MA, El Shafiee MK, et al. Androgenetic alopecia, metabolic syndrome, and insulin resistance: is there any association? A case-control study. Indian Dermatol Online J. 2014;5(3):276–281.
   PubMedGoogle Scholar
• Trieu N, Eslick GD. Alopecia and its association with coronary heart disease and cardiovascular risk factors: a meta-analysis. Int J Cardiol. 2014;176(3):687–695.
   PubMed Web of Science ®Google Scholar
• Pengsalae N, Tanglertsampan C, Phichawong T, et al. Association of early onset androgenetic alopecia and metabolic syndrome in Thai men: a case-control study. J Med Assoc Thai. 2013;96(8):947–951.
   PubMedGoogle Scholar
• Arias-Santiago S, Gutiérrez-Salmerón MT, Castellote-Caballero L, et al. Androgenetic alopecia and cardiovascular risk factors in men and women: a comparative study. J Am Acad Dermatol. 2010;63(3):420–429.
   PubMed Web of Science ®Google Scholar
• Arias-Santiago S, Gutiérrez-Salmerón MT, Castellote-Caballero L, et al. Male androgenetic alopecia and cardiovascular risk factors: a case-control study. Actas Dermosifiliogr. 2010;101(3):248–256.
   PubMedGoogle Scholar
• Acibucu F, Kayatas M, Candan F. The association of insulin resistance and metabolic syndrome in early androgenetic alopecia. Singap Med J. 2010;51:931–936.
   PubMed Web of Science ®Google Scholar
• El Sayed MH, Abdallah MA, Aly DG, et al. Association of metabolic syndrome with female pattern hair loss in women: a case-control study. Int J Dermatol. 2016;55(10):1131–1137.
   PubMed Web of Science ®Google Scholar
• Yi SM, Son SW, Lee KG, et al. Gender-specific association of androgenetic alopecia with metabolic syndrome in a middle-aged Korean population. Br J Dermatol. 2012;167(2):306–313.
   PubMed Web of Science ®Google Scholar
• Mumcuoglu C, Ekmekci TR, Ucak S. The investigation of insulin resistance and metabolic syndrome in male patients with early-onset androgenetic alopecia. Eur J Dermatol. 2011;21:79–82.
   PubMed Web of Science ®Google Scholar
• Ozbas Gok S, Akin Belli A, Dervis E. Is there really relationship between androgenetic alopecia and metabolic syndrome? Dermatol Res Pract. 2015;2015:1–4.
   Web of Science ®Google Scholar
• Matilainen VA, Makinen PK, Keinanen-Kiukaanniemi SM. Early onset of androgenetic alopecia associated with early severe coronary heart disease: a population-based, case-control study. J Cardiovasc Risk. 2001;8(3):147–151.
   PubMedGoogle Scholar
• Rakowska A, Slowinska M, Kowalska-Oledzka E, et al. Dermoscopy in female androgenic alopecia: method standardization and diagnostic criteria. Int J Trichol. 2009;1(2):123–130.
   PubMedGoogle Scholar
• Bhamla SA, Dhurat RS, Saraogi PP. Is trichoscopy a reliable tool to diagnose early female pattern hair loss? Int J Trichol. 2013;5(3):121–125.
   PubMedGoogle Scholar
• Ludwig E. Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex. Br J Dermatol. 1977;97(3):247–254.
   PubMed Web of Science ®Google Scholar
• Alberti KG, Eckel RH, Grundy SM, International Association for the Study of Obesity, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640–1645.
   PubMed Web of Science ®Google Scholar
• Ibrahim MM. Hypertension surveys in the developing world. Lessons from the Egyptian National Hypertension Project (NHP). J Hum Hypertens. 1997;11(11):709–726.
   PubMed Web of Science ®Google Scholar
• Leyden J, Dunlap F, Miller B, et al. Finasteride in the treatment of men with frontal male pattern hair loss. J Am Acad Dermatol. 1999;40(6):930–937.
   PubMed Web of Science ®Google Scholar
• Thompson IM, Goodman PJ, Tangen CM, et al. The influence of finasteride on the development of prostate cancer. N Engl J Med. 2003;349(3):215–224.
   PubMed Web of Science ®Google Scholar
• Kosaka T, Yasumizu Y, Miyazaki Y, et al. Potent increased risk of the initiation of DNA replication in human prostate cancer with the use of 5α-reductase inhibitors. Am J Clin Exp Urol. 2014;12:136–144.
   Google Scholar
• Aguirre GA, De Ita JR, de la Garza RG, et al. Insulin-like growth factor-1 deficiency and metabolic syndrome. J Transl Med. 2016;14(1):3.
   PubMedGoogle Scholar
• Weger N, Schlake T. IGF-I signalling controls the hair growth cycle and the differentiation of hair shafts. J Invest Dermatol. 2005;125(5):873–882.
   PubMed Web of Science ®Google Scholar
• Philpott MP, Sanders DA, Kealey T. Effects of insulin and insulin-like growth factors on cultured human hair follicles: IGF-I at physiologic concentrations is an important regulator of hair follicle growth in vitro. J Invest Dermatol. 1994;102(6):857–861.
   PubMed Web of Science ®Google Scholar
• Ahn SY, Pi LQ, Hwang ST, et al. Effect of IGF-I on hair growth is related to the anti-apoptotic effect of IGF-I and up-regulation of PDGF-A and PDGF-B. Ann Dermatol. 2012;24(1):26–31.
   PubMed Web of Science ®Google Scholar
• Tomita Y, Akiyama M, Shimizu H. PDGF isoforms induce and maintain anagen phase of murine hair follicles. J Dermatol Sci. 2006;43(2):105–115.
   PubMed Web of Science ®Google Scholar
• Cotsarelis G, Millar SE. Towards a molecular understanding of hair loss and its treatment. Trends Mol Med. 2001;7(7):293–301.
   PubMed Web of Science ®Google Scholar
• Botchkareva NV, Kahn M, Ahluwalia G, et al. Survivin in the human hair follicle. J Invest Dermatol. 2007;127(2):479–482.
   PubMed Web of Science ®Google Scholar
• Botchkareva NV, Ahluwalia G, Shander D. Apoptosis in the hair follicle. J Invest Dermatol. 2006;126(2):258–264.
   PubMed Web of Science ®Google Scholar
• Noordam R, Gunn DA, van Drielen K, et al. Both low circulating insulin-like growth factor-1 and high-density lipoprotein cholesterol are associated with hair loss in middleaged women. Br J Dermatol. 2016;175(4):728–734.
   PubMed Web of Science ®Google Scholar
• Lurie R, Ben-Amitai D, Laron Z. Laron syndrome (primary growth hormone insensitivity): a unique model to explore the effect of insulin-like growth factor 1 deficiency on human hair. Dermatol. 2004;208(4):314–318.
   PubMed Web of Science ®Google Scholar
• Trüeb RM. Further clinical evidence for the effect of IGF-1 on hair growth and alopecia. Skin Appendage Disord. 2018;4(2):90–95.
   PubMed Web of Science ®Google Scholar
• Jahoda CA. Cellular and developmental aspects of androgenetic alopecia. Exp Dermatol. 1998;7(5):235–248.
   PubMed Web of Science ®Google Scholar
• Ramos PM, Brianezi G, Martins ACP, et al. Apoptosis in follicles of individuals with female pattern hair loss is associated with perifollicular microinflammation. Int J Cosmet Sci. 2016;38(6):651–654.
   PubMed Web of Science ®Google Scholar
• Elmadhun NY, Sabe AA, Lassaletta AD, et al. Metabolic syndrome impairs notch signaling and promotes apoptosis in chronically ischemic myocardium. J Thorac Cardiovasc Surg. 2014;148(3):1048–1055.
   PubMed Web of Science ®Google Scholar
• Landar A, Zmijewski JW, Dickinson DA, et al. Interaction of electrophilic lipid oxidation products with mitochondria in endothelial cells and formation of reactive oxygen species. Am J Physiol Heart Circ Physiol. 2006;290(5):H1777–787.
   PubMed Web of Science ®Google Scholar
• Mahe YF, Michelet JF, Billoni N, et al. Androgenetic alopecia and microinflammation. Int J Dermatol. 2000;39(8):576–584.
   PubMed Web of Science ®Google Scholar
• Su LH, Chen LS, Chen HH. Factors associated with female pattern hair loss and its prevalence in Taiwanese women: a community-based survey. J Am Acad Dermatol. 2013;69(2):e69–77.
   PubMed Web of Science ®Google Scholar
• Trueb RM. The impact of oxidative stress on hair. Int J Cosmet Sci. 2015;37:25–30.
   PubMed Web of Science ®Google Scholar
• Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365(9468):1415–1428.
   PubMed Web of Science ®Google Scholar
• Roberts CK, Hevener AL, Barnard RJ. Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training. Compr Physiol. 2013;3(1):1–58.
   PubMed Web of Science ®Google Scholar
• Goldman BE, Fisher DM, Ringler SL. Transcutaneus PO2 of the scalp in male pattern baldness: a new piece to the puzzle. Plast Reconstr Surg. 1996;97(6):1109–1117.
   PubMed Web of Science ®Google Scholar
• Lau DC, Dhillon B, Yan H, et al. Adipokines: molecular links between obesity and atheroslcerosis. Am J Physiol Heart Circ Physiol. 2005;288:H203–241.
   Web of Science ®Google Scholar
• Upreti R, Hughes KA, Livingstone DEW, et al. 5α-Reductase type 1 modulates insulin sensitivity in men. J Clin Endocrinol Metab. 2014;99(8):E1397–406.
   PubMed Web of Science ®Google Scholar
• Savage DB, Petersen KF, Shulman GI. Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol Rev. 2007;87(2):507–520.
   PubMed Web of Science ®Google Scholar
• Matilainen V, Laakso M, Hirsso P, et al. Hair loss, insulin resistance, and heredity in middle-aged women. A population-based study. J Cardiovasc Risk. 2003;10(3):227–231.
   PubMedGoogle Scholar
• Ekmekci TR, Ucak S, Basat O, et al. The presence of insulin resistance and comparison of various insulin sensivity indices in women with androgenetic alopecia. Eur J Dermatol. 2007;17(1):21–25.
   PubMed Web of Science ®Google Scholar
• Kartal D, Borlu M, Çınar SL, et al. The association of androgenetic alopecia and insulin resistance is independent of hyperandrogenemia: a case-control study. Austr J Dermatol. 2016;57(3):e88–92.
   PubMed Web of Science ®Google Scholar
• Sadgrove NJ. The new paradigm for androgenetic alopecia and plant-based folk remedies: 5α-reductase inhibition, reversal of secondary microinflammation and improving insulin resistance. J Ethnopharmacol. 2018;227:206–236.
   PubMed Web of Science ®Google Scholar
• Hazlehurst JM, Oprescu AI, Nikolaou N, et al. Dual-5-reductase inhibition promotes hepatic lipid accumulation in man. J Clin Endocrinol Metab. 2016;101(1):103–113.
   PubMed Web of Science ®Google Scholar
• Jeong K, Lee YJ, Kim JE, et al. Repeated microneedle stimulation induce the enhanced expression of hair-growth related genes. Int J Trichol. 2012;4:117.
   Google Scholar
• Kim BJ, Lim YY, Kim HM, et al. Hair follicle regeneration in mice after wounding by microneedle roller. Int J Trichol. 2012;4:117.
   Google Scholar
• O’Toole EA, Mellerio JE. Wound healing. In: Burns TB, Cox N, Griffiths C, editors. Rook's textbook of dermatology. 8th ed. Hoboken, NJ: Blackwell Publishing; 2010. p. 14.1–27.
   Google Scholar
• Tsuboi R, Itami S, Inui S, Guidelines Planning Committee for the Management of Androgenetic Alopecia, et al. Guidelines for the management of androgenetic alopecia (2010). J Dermatol. 2012;39(2):113–120.
   PubMed Web of Science ®Google Scholar
• Gupta AK, Daigle D. The use of low-level light therapy in the treatment of androgenetic alopecia and female pattern hair loss. J Dermatol Treat. 2014;25(2):162–163.
   PubMed Web of Science ®Google Scholar